Work

P47.02 EV-202: Phase 2 Study of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors Including Non-Small Cell Lung Cancer

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.495

Authors: K. Muro, J. Yang Bruce, J. Baranda, T. Feinstein, X. Li, S. Gorla, C. Wu, F. Braiteh

Institutions: Aichi Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, University of Kansas Medical Center, Piedmont Cancer Institute, Seagen (United States), Astellas Pharma (United States), Comprehensive Cancer Centers of Nevada

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3207443518

Cites:

Cited by: 3

Related to: 10